Sbi Securities Co., Ltd. Arcturus Therapeutics Holdings Inc. Transaction History
Sbi Securities Co., Ltd.
- $3 Trillion
- Q1 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 64 shares of ARCT stock, worth $835. This represents 0.0% of its overall portfolio holdings.
Number of Shares
64
Previous 63
1.59%
Holding current value
$835
Previous $1.07 Million
36.58%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ARCT
# of Institutions
161Shares Held
26.1MCall Options Held
312KPut Options Held
96.5K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$61.3 Million0.11% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$34.6 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.93MShares$25.2 Million0.01% of portfolio
-
Nikko Asset Management Americas, Inc.1.93MShares$25.2 Million0.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.75MShares$22.8 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $347M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...